(VRSK) Verisk Analytics - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US92345Y1064
Stock: Data, Analytics, Software, Risk, Claims
Total Rating 48
Risk 84
Buy Signal -0.63
| Risk 5d forecast | |
|---|---|
| Volatility | 35.4% |
| Relative Tail Risk | -8.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.16 |
| Alpha | -35.01 |
| Character TTM | |
|---|---|
| Beta | 0.274 |
| Beta Downside | 0.298 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.98% |
| CAGR/Max DD | 0.09 |
EPS (Earnings per Share)
Revenue
Description: VRSK Verisk Analytics February 28, 2026
Verisk Analytics, Inc. (NASDAQ: VRSK) delivers data-driven analytics and technology platforms that support underwriting, pricing, claims processing, fraud detection, and catastrophe modeling for property- and casualty insurers, life insurers, and reinsurers across the United States and internationally.
In its most recent fiscal year (2023), Verisk generated $9.2 billion in revenue, up 6 % year-over-year, and posted an operating margin of 27 %, reflecting strong demand for its risk-selection and workflow-automation solutions. The company’s Q1 2024 earnings per share of $1.12 beat consensus estimates, underscoring the resilience of its subscription-based model amid a backdrop of rising insured-loss costs and accelerating digital transformation in the insurance sector.
For a deeper dive into how Verisk’s data capabilities compare with emerging platforms, consider exploring ValueRay’s research tools.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 908.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA -2.14 > 1.0 |
| NWC/Revenue: 15.14% < 20% (prev -11.36%; Δ 26.49% < -1%) |
| CFO/TA 0.23 > 3% & CFO 1.44b > Net Income 908.3m |
| Net Debt (2.86b) to EBITDA (1.69b): 1.69 < 3 |
| Current Ratio: 1.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (139.1m) vs 12m ago -1.75% < -2% |
| Gross Margin: 67.31% > 18% (prev 0.69%; Δ 6662 % > 0.5%) |
| Asset Turnover: 58.75% > 50% (prev 67.57%; Δ -8.82% > 0%) |
| Interest Coverage Ratio: 8.07 > 6 (EBITDA TTM 1.69b / Interest Expense TTM 170.9m) |
Altman Z'' 7.79
| A: 0.08 (Total Current Assets 2.77b - Total Current Liabilities 2.30b) / Total Assets 6.20b |
| B: 1.26 (Retained Earnings 7.81b / Total Assets 6.20b) |
| C: 0.26 (EBIT TTM 1.38b / Avg Total Assets 5.23b) |
| D: 1.35 (Book Value of Equity 7.92b / Total Liabilities 5.89b) |
| Altman-Z'' Score: 7.79 = AAA |
Beneish M -3.33
| DSRI: 0.85 (Receivables 470.8m/517.7m, Revenue 3.07b/2.88b) |
| GMI: 1.02 (GM 67.31% / 68.73%) |
| AQI: 0.72 (AQ_t 0.44 / AQ_t-1 0.61) |
| SGI: 1.07 (Revenue 3.07b / 2.88b) |
| TATA: -0.09 (NI 908.3m - CFO 1.44b) / TA 6.20b) |
| Beneish M-Score: -3.33 (Cap -4..+1) = AA |
What is the price of VRSK shares?
As of March 01, 2026, the stock is trading at USD 207.57 with a total of 3,301,741 shares traded.
Over the past week, the price has changed by +13.74%, over one month by -4.03%, over three months by -7.58% and over the past year by -27.96%.
Over the past week, the price has changed by +13.74%, over one month by -4.03%, over three months by -7.58% and over the past year by -27.96%.
Is VRSK a buy, sell or hold?
Verisk Analytics has received a consensus analysts rating of 3.39.
Therefor, it is recommend to hold VRSK.
- StrongBuy: 3
- Buy: 3
- Hold: 10
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the VRSK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 221.8 | 6.8% |
| Analysts Target Price | 221.8 | 6.8% |
VRSK Fundamental Data Overview February 24, 2026
P/E Trailing = 28.0769
P/E Forward = 31.25
P/S = 8.2982
P/B = 110.9069
P/EG = 2.9688
Revenue TTM = 3.07b USD
EBIT TTM = 1.38b USD
EBITDA TTM = 1.69b USD
Long Term Debt = 3.21b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.54b USD (from shortTermDebt, last quarter)
Debt = 5.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.86b USD (from netDebt column, last quarter)
Enterprise Value = 28.36b USD (25.50b + Debt 5.04b - CCE 2.18b)
Interest Coverage Ratio = 8.07 (Ebit TTM 1.38b / Interest Expense TTM 170.9m)
EV/FCF = 23.79x (Enterprise Value 28.36b / FCF TTM 1.19b)
FCF Yield = 4.20% (FCF TTM 1.19b / Enterprise Value 28.36b)
FCF Margin = 38.79% (FCF TTM 1.19b / Revenue TTM 3.07b)
Net Margin = 29.56% (Net Income TTM 908.3m / Revenue TTM 3.07b)
Gross Margin = 67.31% ((Revenue TTM 3.07b - Cost of Revenue TTM 1.00b) / Revenue TTM)
Gross Margin QoQ = 59.60% (prev 70.13%)
Tobins Q-Ratio = 4.58 (Enterprise Value 28.36b / Total Assets 6.20b)
Interest Expense / Debt = 1.13% (Interest Expense 56.9m / Debt 5.04b)
Taxrate = 19.48% (47.7m / 244.9m)
NOPAT = 1.11b (EBIT 1.38b * (1 - 19.48%))
Current Ratio = 1.20 (Total Current Assets 2.77b / Total Current Liabilities 2.30b)
Debt / Equity = 16.30 (Debt 5.04b / totalStockholderEquity, last quarter 309.0m)
Debt / EBITDA = 1.69 (Net Debt 2.86b / EBITDA 1.69b)
Debt / FCF = 2.40 (Net Debt 2.86b / FCF TTM 1.19b)
Total Stockholder Equity = 280.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 17.37% (Net Income 908.3m / Total Assets 6.20b)
RoE = 324.3% (Net Income TTM 908.3m / Total Stockholder Equity 280.1m)
RoCE = 39.50% (EBIT 1.38b / Capital Employed (Equity 280.1m + L.T.Debt 3.21b))
RoIC = 26.82% (NOPAT 1.11b / Invested Capital 4.14b)
WACC = 5.94% (E(25.50b)/V(30.54b) * Re(6.93%) + D(5.04b)/V(30.54b) * Rd(1.13%) * (1-Tc(0.19)))
Discount Rate = 6.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.18%
[DCF] Terminal Value 87.17% ; FCFF base≈1.08b ; Y1≈1.20b ; Y5≈1.57b
[DCF] Fair Price = 307.0 (EV 45.64b - Net Debt 2.86b = Equity 42.79b / Shares 139.4m; r=5.94% [WACC]; 5y FCF grow 12.79% → 2.90% )
EPS Correlation: 80.64 | EPS CAGR: 8.51% | SUE: 4.0 | # QB: 1
Revenue Correlation: 47.83 | Revenue CAGR: 5.22% | SUE: 0.98 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.75 | Chg7d=-0.091 | Chg30d=-0.091 | Revisions Net=-1 | Analysts=15
EPS current Year (2026-12-31): EPS=7.65 | Chg7d=-0.054 | Chg30d=-0.054 | Revisions Net=-1 | Growth EPS=+6.8% | Growth Revenue=+4.9%
EPS next Year (2027-12-31): EPS=8.59 | Chg7d=+0.019 | Chg30d=+0.018 | Revisions Net=+3 | Growth EPS=+12.3% | Growth Revenue=+7.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.4% (Discount Rate 7.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = -1.4% (Analyst 3.0% - Implied 4.4%)
P/E Forward = 31.25
P/S = 8.2982
P/B = 110.9069
P/EG = 2.9688
Revenue TTM = 3.07b USD
EBIT TTM = 1.38b USD
EBITDA TTM = 1.69b USD
Long Term Debt = 3.21b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.54b USD (from shortTermDebt, last quarter)
Debt = 5.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.86b USD (from netDebt column, last quarter)
Enterprise Value = 28.36b USD (25.50b + Debt 5.04b - CCE 2.18b)
Interest Coverage Ratio = 8.07 (Ebit TTM 1.38b / Interest Expense TTM 170.9m)
EV/FCF = 23.79x (Enterprise Value 28.36b / FCF TTM 1.19b)
FCF Yield = 4.20% (FCF TTM 1.19b / Enterprise Value 28.36b)
FCF Margin = 38.79% (FCF TTM 1.19b / Revenue TTM 3.07b)
Net Margin = 29.56% (Net Income TTM 908.3m / Revenue TTM 3.07b)
Gross Margin = 67.31% ((Revenue TTM 3.07b - Cost of Revenue TTM 1.00b) / Revenue TTM)
Gross Margin QoQ = 59.60% (prev 70.13%)
Tobins Q-Ratio = 4.58 (Enterprise Value 28.36b / Total Assets 6.20b)
Interest Expense / Debt = 1.13% (Interest Expense 56.9m / Debt 5.04b)
Taxrate = 19.48% (47.7m / 244.9m)
NOPAT = 1.11b (EBIT 1.38b * (1 - 19.48%))
Current Ratio = 1.20 (Total Current Assets 2.77b / Total Current Liabilities 2.30b)
Debt / Equity = 16.30 (Debt 5.04b / totalStockholderEquity, last quarter 309.0m)
Debt / EBITDA = 1.69 (Net Debt 2.86b / EBITDA 1.69b)
Debt / FCF = 2.40 (Net Debt 2.86b / FCF TTM 1.19b)
Total Stockholder Equity = 280.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 17.37% (Net Income 908.3m / Total Assets 6.20b)
RoE = 324.3% (Net Income TTM 908.3m / Total Stockholder Equity 280.1m)
RoCE = 39.50% (EBIT 1.38b / Capital Employed (Equity 280.1m + L.T.Debt 3.21b))
RoIC = 26.82% (NOPAT 1.11b / Invested Capital 4.14b)
WACC = 5.94% (E(25.50b)/V(30.54b) * Re(6.93%) + D(5.04b)/V(30.54b) * Rd(1.13%) * (1-Tc(0.19)))
Discount Rate = 6.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.18%
[DCF] Terminal Value 87.17% ; FCFF base≈1.08b ; Y1≈1.20b ; Y5≈1.57b
[DCF] Fair Price = 307.0 (EV 45.64b - Net Debt 2.86b = Equity 42.79b / Shares 139.4m; r=5.94% [WACC]; 5y FCF grow 12.79% → 2.90% )
EPS Correlation: 80.64 | EPS CAGR: 8.51% | SUE: 4.0 | # QB: 1
Revenue Correlation: 47.83 | Revenue CAGR: 5.22% | SUE: 0.98 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.75 | Chg7d=-0.091 | Chg30d=-0.091 | Revisions Net=-1 | Analysts=15
EPS current Year (2026-12-31): EPS=7.65 | Chg7d=-0.054 | Chg30d=-0.054 | Revisions Net=-1 | Growth EPS=+6.8% | Growth Revenue=+4.9%
EPS next Year (2027-12-31): EPS=8.59 | Chg7d=+0.019 | Chg30d=+0.018 | Revisions Net=+3 | Growth EPS=+12.3% | Growth Revenue=+7.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.4% (Discount Rate 7.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = -1.4% (Analyst 3.0% - Implied 4.4%)